Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2011-04-20Differential Risks for Melanoma: p16 and DNA Repair
-
CLINICAL_TRIALS study record update · 2011-03-28Injection of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune Response
-
CLINICAL_TRIALS study record update · 2011-03-24Efficacy and Safety of High-dose Treatment With the Immunomodulator Interferon-α-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma.
-
CLINICAL_TRIALS study record update · 2011-03-10Partner Assistance in Learning and Performing Skin Self-Examination
-
CLINICAL_TRIALS study record update · 2011-02-23A Phase I/II Study of Sunitinib and Dacarbazine in Patients With Metastatic Melanoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2011-02-23Phase III Randomized, Placebo Controlled Study of Sorafenib in Repeated Cycles of 21 Days in Combination With Paclitaxel/Carboplatin Chemotherapy in Subjects With Unresectable Stage III or Stage IV Melanoma.
-
CLINICAL_TRIALS study record update · 2011-01-28A Randomized Study Comparing MDX-010 (CTLA-4) Alone or in Combination With DTIC in the Treatment of Patients With Chemotherapy Naїve Metastatic Melanoma.
-
CLINICAL_TRIALS study record update · 2011-01-25A Phase II, Multi-center, Open-label, Uncontrolled Study to Evaluate the Efficacy and Safety of BAY 43-9006 Given Daily in Combination With Repeated 21-Day Cycles of Dacarbazine (DTIC) Chemotherapy in Subjects With Advanced Metastatic Melanoma.
-
CLINICAL_TRIALS study record update · 2011-01-24Comparison of Diagnostic and Biopsy/Referral Sensitivity to Melanoma Between Three Groups of Physicians and MelaFind
-
CLINICAL_TRIALS study record update · 2011-01-13A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b (PEG-Intron)and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2011-01-12Combined Treatment of Sorafenib and Pegylated Interferon α2b in Stage IV Metastatic Melanoma: a Prospective Non-randomized, Multicenter Phase II Study
-
CLINICAL_TRIALS study record update · 2010-12-17Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2010-12-14Nordic Randomized Phase III Trial of Two Different Durations of Adjuvant Therapy With Intermediate-dose Interferon Alfa-2b in Patients With High-risk Melanoma
-
CLINICAL_TRIALS study record update · 2010-10-21Pilot Phase II Trial for the Evaluation of the Effect of Systemic Low-dose IL-2 on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With GM-CSF-in-Adjuvant, in Patients With High Risk Melanoma
-
CLINICAL_TRIALS study record update · 2010-10-13Randomized, Multicenter Phase III Trial Comparing Adjuvant Treatment With PegIntron Over 36 Months Versus Reference Treatment With IntronA Over 18 Months in Cutaneous Melanoma Patients AJCC Stage II (>=1.5 mm Clinically Node Negative)
-
CLINICAL_TRIALS study record update · 2010-08-18A Randomised Trial of Surgical Excision Margins for Thick Primary Cutaneous Melanoma (>2 mm). A Multicenter Trial Comparing 2-cm vs 4-cm
-
CLINICAL_TRIALS study record update · 2010-08-05A Phase IIa Study of TLN-232 as Second-line Therapy for Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2010-08-03A Phase I Multicenter, Open Label, Clinical Trial of Immune Response, Safety and Tolerability of DNA Vector pPRA-PSM With Synthetic Peptides E-PRA and E-PSM in Subjects With Advance Solid Malignancies
-
CLINICAL_TRIALS study record update · 2010-05-10Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors
-
CLINICAL_TRIALS study record update · 2010-04-15The Impact of Total Body Skin Examination on Skin Cancer Detection
-
CLINICAL_TRIALS study record update · 2010-03-02A Randomized, Double-Blind, Multi-center, Phase II Fixed Dose Study of Multiple Doses of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma
-
CLINICAL_TRIALS study record update · 2010-02-03Dose-escalating, Pilot Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ALS-357 Topically Administered to Patients With Cutaneous Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2009-12-02Active Specific Intranodal Immunotherapy With a Recombinant Vaccinia Virus Expressing Three Melanoma Associated Epitopes and Two Costimulatory Molecules, Followed by Immunization With Synthetic Melanoma Associated Epitopes. A Phase I/II Trial in Patients With Stages IIb to IV Melanoma
-
CLINICAL_TRIALS study record update · 2009-11-11Evaluation of Pigmented Skin Lesions With MelaFind(R) System
-
CLINICAL_TRIALS study record update · 2009-10-21A Pilot Study of Intraoperative Gamma Camera Imaging During Sentinel Node Biopsy for Melanoma